The FDA has received 3,014 adverse event reports for dogs that name Levothyroxine.
- 3,014 reports name Levothyroxine in dogs, which is 0.3% of all 1,001,380 dog reports. A report counts under every active ingredient it names.
- 44% are marked serious and 8.4% record a death or euthanasia; across all dog reports those figures are 29% and 5.4%.
- 16% are complaints that the product did not work (38% across all dog reports).
- The clinical signs reported most are vomiting, lethargy and diarrhoea.
- The FDA lists 2 approved animal drug applications containing Levothyroxine for dogs, the earliest approved in 2016.
- None of this is a rate. The FDA data does not record how many dogs were given Levothyroxine, so it cannot say how often any of this happens.
How the reports break down
| What the reports say | Reports | Share of this medicine's reports | All dog reports |
|---|---|---|---|
| Marked seriousthe FDA record flags the report as serious | 1,335 | 44% | 29% |
| Death or euthanasiathe outcome recorded in the report, with no finding of cause | 253 | 8.4% | 5.4% |
| Did not worka complaint that the product failed to work, which the FDA files as an adverse event | 494 | 16% | 38% |
| Seizurea seizure or convulsion is among the clinical signs | 205 | 6.8% | 4.4% |
| Not used per labelthe report says the product was not used the way its label directs | 1,048 | 35% | 21% |
Where on the body do the reported signs sit?
Not on the body: Whole body 14% Did not work 5.6% How it was given 4.1%
- Stomach and gut38%vomiting, diarrhoea, emesis, weight loss and 3 more
- Blood and organ tests18%other abnormal test result, elevated alanine aminotransferase (alt), elevated serum alkaline phosphatase (sap), elevated thyroxine (t4) and 2 more
- Whole body14%lethargy, death by euthanasia, lethargy
- Thirst and urination6.6%polydipsia, polyuria
- Brain and nerves6.2%seizure, ataxia
- Did not work5.6%lack of efficacy
- How it was given4.1%overdose
- Heart and breathing4.1%panting
- Behaviour2.1%behavioural disorder
- Skin and coat1.9%itching
Each figure is a share of sign mentions among the 25 signs reported most for Levothyroxine in dogs. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.
Clinical signs reported most
- Vomiting443 15%
- Lethargy330 11%
- Diarrhoea309 10%
- Emesis306 10%
- Lack of efficacy247 8.2%
- Weight loss207 6.9%
- Overdose184 6.1%
- Panting184 6.1%
Reports received per year
Is it approved for dogs?
The FDA lists 2 approved animal drug applications containing Levothyroxine for dogs, the earliest approved in 2016.
| Product | Form | Approved for | First approved | FDA application |
|---|---|---|---|---|
| Thyro-Tabs CanineLloyd, Inc. | Tablet RX | Dog | 2016 | 141-448 |
| ThyrokareNeogen Corp. | Tablet RX | Dog | 2021 | 141-539 |
From the FDA record for Thyro-Tabs Canine: For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
What can you do next?
Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.
Where can you go from this result?
This result is one of 94 in the lookup. See Levothyroxine in cats (29 reports). Open it in the lookup to set it beside another medicine, or read how the counts were collected.
- Metronidazole in dogs3,094
- Cephalexin in dogs2,680
- Famotidine in dogs2,644
- Fluoxetine in dogs2,588
To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.
Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.